Literature DB >> 1552205

Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli.

T Yamamoto1, P Echeverria, T Yokota.   

Abstract

Clinical isolates of enteroaggregative Escherichia coli (EAggEC) were tested for their in vitro susceptibilities to 27 antimicrobial agents. Marked drug resistance was observed with sulfamethoxazole, ampicillin, and chloramphenicol in contrast to such antimicrobial agents as cefixime, sparfloxacin, and ciprofloxacin. One of the EAggEC strains carried a plasmid that conferred on its host resistance to ampicillin, tetracycline, sulfamethoxazole, streptomycin, and spectinomycin and an ability to adhere to child ileal villi or HeLa cells in the characteristic aggregative pattern. This plasmid also mediated D-mannose-resistant hemagglutinin production and bacterial clump formation (autoagglutination). The data demonstrate appearance of marked drug resistance and an intestine-adherence and drug-resistance plasmid in the newest category of diarrheagenic E. coli.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552205     DOI: 10.1093/infdis/165.4.744

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.

Authors:  Rebecca Dillingham; Paul Leger; Carole-Anne Beauharnais; Erica Miller; Angela Kashuba; Steven Jennings; Kathryn Dupnik; Amidou Samie; Etna Eyma; Richard Guerrant; Jean Pape; Daniel Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Enteroaggregative Escherichia coli: An Emerging Pathogen.

Authors:  David B. Huang; Hoonmo Koo; Herbert L. DuPont
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

3.  New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family.

Authors:  Nadia Boisen; Carsten Struve; Flemming Scheutz; Karen A Krogfelt; James P Nataro
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

4.  A novel cryohemagglutinin associated with adherence of enteroaggregative Escherichia coli.

Authors:  T Yamamoto; N Wakisaka; T Nakae
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 5.  Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Authors:  Dakshina M Jandhyala; Vijay Vanguri; Erik J Boll; Yushuan Lai; Beth A McCormick; John M Leong
Journal:  Infect Dis Clin North Am       Date:  2013-07-24       Impact factor: 5.982

6.  Multidrug-resistant enteroaggregative Escherichia coli associated with persistent diarrhea in Kenyan children.

Authors:  W K Sang; J O Oundo; J K Mwituria; P G Waiyaki; M Yoh; T Iida; T Honda
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 7.  Enteroaggregative Escherichia coli.

Authors:  J P Nataro; T Steiner; R L Guerrant
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

8.  Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages.

Authors:  Iruka N Okeke; Faith Wallace-Gadsden; Hannah R Simons; Nicholas Matthews; Amy S Labar; Jennifer Hwang; John Wain
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

9.  Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model.

Authors:  S Tzipori; J Montanaro; R M Robins-Browne; P Vial; R Gibson; M M Levine
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.

Authors:  Roy R Chaudhuri; Mohammed Sebaihia; Jon L Hobman; Mark A Webber; Denisse L Leyton; Martin D Goldberg; Adam F Cunningham; Anthony Scott-Tucker; Paul R Ferguson; Christopher M Thomas; Gad Frankel; Christoph M Tang; Edward G Dudley; Ian S Roberts; David A Rasko; Mark J Pallen; Julian Parkhill; James P Nataro; Nicholas R Thomson; Ian R Henderson
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.